Impact of baseline insulin regimen on glycemic response to a group medical clinic intervention

Diabetes Care

Volumn 36, Issue 7, 2013, Pages 1954-1960

  Crowley, Matthew J ^a,b   Melnyk, Stephanie D ^a,c   Coffman, Cynthia J ^a,d   Jeffreys, Amy S ^a,d   Edelman, David ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNC Hamner Institute for Drug Safety Sciences   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE DELIVERY; HUMAN; HYPOGLYCEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CARE; SELF CONCEPT; TREATMENT OUTCOME; VETERAN;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED;

EID: 84886071966     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1905     Document Type: Article

References (40)

1. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004;27(Suppl 2): B10-B21
2. Gilmer TP, O'Connor PJ, Rush WA, et al. Predictors of health care costs in adultswith diabetes. Diabetes Care 2005;28:59-64
3. Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-932
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-853
6. Hartz A, Kent S, James P, Xu Y, Kelly M, Daly J. Factors that influence improvement for patients with poorly controlled type 2 diabetes. Diabetes Res Clin Pract 2006;74:227-232
7. Schmucker D. Group Medical Appointments: An Introduction for Health Professionals. Sudbury, MA, Jones & Bartlett, 2006
8. Sadur CN, Moline N, Costa M, et al. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care 1999;22: 2011-2017
9. Wagner EH, Grothaus LC, Sandhu N, et al. Chronic care clinics for diabetes in primary care: a system-wiDe randomized trial. Diabetes Care 2001;24:695-700
10. Trento M, Passera P, Tomalino M, et al. Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up. Diabetes Care 2001;24:995-1000
11. Clancy DE, Cope DW, Magruder KM, Huang P, Salter KH, Fields AW. Evaluating group visits in an uninsured or inadequately insured patient population with uncontrolled type 2 diabetes. Diabetes Educ 2003;29:292-302
12. Trento M, Passera P, Borgo E, et al. A 3-year prospective randomized controlled clinical trial of group care in type 1 diabetes. Nutr Metab Cardiovasc Dis 2005; 15:293-301
13. Clancy DE, Huang P, Okonofua E, Yeager D, MagruderKM.Group visits: promoting adherence to diabetes guidelines. J Gen Intern Med 2007;22:620-624
14. Trento M, Gamba S, Gentile L, et al.; ROMEO Investigators. Rethink Organization to iMprove Education andOutcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes. Diabetes Care 2010;33:745-747
15. Taveira TH, Friedmann PD, Cohen LB, et al. Pharmacist-led group medical appointment model in type 2 diabetes. Diabetes Educ 2010;36:109-117
16. Edelman D, Fredrickson SK, Melnyk SD, et al. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. Ann Intern Med 2010;152:689-696
17. Naik AD, Palmer N, Petersen NJ, et al. Comparative effectiveness of goal setting in diabetes mellitus group clinics: randomized clinical trial. Arch Intern Med 2011;171:453-459
18. Taveira TH, Dooley AG, Cohen LB, Khatana SA, Wu WC. Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Ann Pharmacother 2011;45:1346-1355
19. Gutierrez N, Gimple NE, Dallo FJ, Foster BM, Ohagi EJ. Shared medical appointments in a residency clinic: an exploratory study among Hispanics with diabetes. Am J Manag Care 2011;17(6 Spec No.):e212-e214
20. Edelman D, McDuffie JR, Oddone E, Gierisch JM, Nagi A, Williams JW Jr. Shared Medical Appointments for Chronic Medical Conditions: A Systematic Review. VA-ESP Project #09- 010; 2012. Available at: http://www .hsrd.research.va.gov/ publications/esp/ shared-med-αppt-EXEC.pdf. Accessed November 5, 2012
21. Ziemer DC, Miller CD, Rhee MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ 2005;31:564-571
22. Jeavons D, Hungin AP, Cornford CS. Patients with poorly controlled diabetes in primary care: healthcare clinicians' beliefs and attitudes. Postgrad Med J 2006;82: 347-350
23. Hayes RP, Fitzgerald JT, Jacober SJ. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes. Int J Clin Pract 2008;62:860-868
24. Harris SB, Kapor J, Lank CN, Willan AR, Houston T. Clinical inertia in patients with T2DM requiring insulin in family practice. Can Fam Physician 2010;56: e418-e424
25. Cuddihy RM, Philis-Tsimikas A, Nazeri A. Type 2 diabetes care and insulin intensification: is a more multidisciplinary approach needed? Results from the MODIFY survey. Diabetes Educ 2011;37:111-123
26. American Diabetes Association. Standards of medical care in diabetesd2012. Diabetes Care 2012;35(Suppl 1):S11-S63
27. Bailey CJ, Kodack M. Patient adherence to medication requirements for therapy of type 2 diabetes. Int J Clin Pract 2011;65: 314-322
28. Williams GC, Freedman ZR, Deci EL. Supporting autonomy to motivate patients with diabetes for glucose control. Diabetes Care 1998;21:1644-1651
29. Williams GC, McGregor HA, Zeldman A, Freedman ZR, Deci EL. Testing a selfdetermination theory process model for promoting glycemic control through diabetes self-management.Health Psychol 2004;23:58-66
30. Williams GC, PatrickH, Niemiec CP, et al. Reducing the health risks of diabetes: how self-determination theory may help improve medication adherence and quality of life. Diabetes Educ 2009;35:484-492
31. Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. Hoboken, NJ, Wiley, 2011
32. Liu GF, Lu K, Mogg R, Mallick M, Mehrotra DV. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? Stat Med 2009;28:2509-2530
33. Senn S. Change frombaseline and analysis of covariance revisited. Stat Med 2006;25: 4334-4344
34. Little RJA, Rubin DB. Statistical Analysis With Missing Data. Hoboken, NJ, Wiley, 2002, p. 112-144
35. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001;24:561-587
36. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a metaanalysis of the effect on glycemic control. Diabetes Care 2002;25:1159-1171
37. Tshiananga JK, Kocher S, Weber C, Erny- Albrecht K, Berndt K, Neeser K. The effect of nurse-led diabetes self-management education on glycosylated hemoglobin and cardiovascular risk factors: a metaanalysis. Diabetes Educ 2012;38:108-123
38. Skaff M, Mullan J, Fisher L, Chesla C. A contextual model of control beliefs, behavior, and health: Latino and European Americans with type 2 diabetes. Psychol Health 2003;18:295-312
39. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care 1995;18:754-760
40. US Department of Veteran Affairs. VHA Office of Quality, Safety and Value. Quality of Care. 2012. Available at: http://www.qualityandsafety.va.gov/ qualityofcare/ measures/ diabetes-poor-hba1c-control.asp. Accessed July 3, 2012